Completed NA INTERVENTIONAL 3-arm NCT01370837

Neurogenic Inflammation in Diabetes

Neurogenic Inflammation in Diabetic Polyneuropathy and Charcot Neuro-osteoarthropathy: Response to Intracutaneous Candida Albicans

Sponsor: Dutch Diabetes Research Foundation

Conditions Arthropathy, Neurogenic Diabetes Mellitus Polyneuropathies

Interventions Intracutaneous injection of Candida albicans antigen. Temperature measurement.

Updated 7 times since 2017 Last updated: Apr 16, 2015 Started: May 31, 2012 Primary completion: Jan 31, 2015 Completion: Jan 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01370837, this NA trial focuses on Arthropathy, Neurogenic and Diabetes Mellitus and remains completed. Sponsored by Dutch Diabetes Research Foundation, it has been updated 7 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2023 — Jul 2024 [monthly]

Completed NA
Dec 2022 — Jan 2023 [monthly]

Completed NA
Jan 2021 — Dec 2022 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

May 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dutch Diabetes Research Foundation
Maastricht University Medical Center

Data source: Maastricht University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Maastricht, Netherlands